Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRC2.L Regulatory News (RC2)

  • There is currently no data for RC2

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Annual Results for 31 December 2014

10 Jun 2015 16:37

RNS Number : 8200P
Reconstruction Capital II Ltd
10 June 2015
 



10 June 2015

Reconstruction Capital II Limited (the "Company")

 

Annual Report and Audited Consolidated Financial Statements

for the year ended 31 December 2014

 

Reconstruction Capital II Limited ("RC2", the "Company" or the "Group"), a closed-end investment company incorporated in the Cayman Islands admitted to trading on the AIM market of the London Stock Exchange, today announces its results for the year ended 31 December 2014.

 

Copies of the Company's annual report will today be posted to shareholders. The annual report is also available to view on the Company's website http://www.reconstructioncapital2.com.

 

Financial highlights

· The audited net asset value as at 31 December 2014 was EUR 0.3775 per share (EUR 0.3287 per share as at 31 December 2013), a 14.8% increase over the year;

· The Directors do not recommend the payment of a dividend.

 

Operational highlights

 

Private Equity Programme

 

RC2 did not make any new investments under its Private Equity Programme, and continued to pursue a number of exits, both from its investee companies as well as from certain assets held by them. The investments held under the Private Equity Programme had a fair value of EUR 44m at the end of 2014, an increase of 16.1% year-on-year. This was primarily due to the increase in market value of the Albalact SA holding by 69% to EUR 9.7m.

 

Trading Programme

 

RC2 did not modify its positions in listed equities held under its Trading Programme in 2014. At the end of 2014, RC2's listed equities held under the Trading Programme had a total market value of EUR 0.3m. All of the investments held under the Trading Programme were in Romanian equities.

 

For further information, please contact:

 

Reconstruction Capital II Limited

Ion Florescu / Anca Moraru

Tel: +40 21 3167680

 

Grant Thornton UK LLP (Nominated Adviser)

Philip Secrett / Harrison Clarke

Tel: +44 (0) 20 7383 5100

 

 

 

 

 

ADVISER'S REPORT

 

On 31 December 2014, Reconstruction Capital II Limited ("RC2") had a total audited net asset value ("NAV") of EUR 37.7m or EUR 0.3775 per share, a 14.8% increase over the year, primarily due to an increase in the market value of its shareholding in Albalact SA which is listed on the Bucharest Stock Exchange.

 

RC2's audited undiluted NAV per share of EUR 0.3775 as at the end of 2014 compares to an unaudited published NAV per share of EUR 0.3771. The fully diluted NAV per share of EUR 0.2812 as at the end of 2014 compares to an unaudited published NAV per share of EUR 0.2810. The variance between the audited and published NAV's is a result of the consolidation of New Europe Capital Limited, which is not consolidated in the published NAV.

 

At the end of 2014, RC2 had cash and cash equivalents of EUR 0.7m. RC2's borrowings, after allocating EUR 0.62m of the proceeds from the convertible loan note to equity reserves in accordance with applicable accounting standards, amounted to EUR 8.0m, whilst suppliers' liabilities amounted to EUR 0.8m.

 

In 2014, RC2 issued a convertible loan note of EUR 8.45m, the proceeds of which enabled the Company to repay prior borrowings and overdue suppliers while providing working capital for its current operations.

 

Private Equity Programme

 

RC2 did not make any new investments under its Private Equity Programme, and continued to pursue a number of exits, both from its investee companies as well as from certain assets held by them. The investments held under the Private Equity Programme had a fair value of EUR 44m at the end of 2014, an increase of 16.1% year-on-year. This was primarily due to the increase in market value of the Albalact SA holding by 69% to EUR 9.7m. All four investments in Romania (Policolor SA, Top Factoring SRL and its sister company Glasro Holdings Limited, Mamaia Resort Hotels SRL and Albalact SA) continue to generate positive EBITDA and in the case of Glasro and Albalact free cash flow in the form of dividends. Klas DOO, the Serbian bakery, reported an improved valuation of EUR 0.3m, in part a result of RC2's exchange of half of its shareholder loans for a 40.9% shareholding in the company taking its overall stake to 52%.

 

Trading Programme

 

RC2 did not modify its positions in listed equities held under its Trading Programme in 2014. At the end of 2014, RC2's listed equities held under the Trading Programme had a total market value of EUR 0.3m. All of the investments held under the Trading Programme were in Romanian equities.

 

Outlook

 

Both the Romanian and Bulgarian economies which reported increases in GDP during 2014 of 2.9% and 1.7% respectively are expected to grow during 2015. Increased private consumption and recovering investment are expected to be the main drivers for Romania's GDP growth in 2015, whereas the Bulgarian economy would benefit from higher international demand resulting in higher net exports. In contrast, Serbia's economy is expected to languish with GDP expected to contract a further 0.5% in 2015 as the government tries to correct macro-economic imbalances.

 

Events after the reporting period

 

Effective 1 January 2015, New Europe Capital DOO (the Serbia-based investment adviser) and New Europe Capital Limited (the UK-based investment manager) ceased to work for RC2. RC2 continued to be advised by its Romania-based Adviser, New Europe Capital SRL.

 

New Europe Capital SRL

INVESTMENT POLICY

 

Private Equity Programme

Under the Private Equity Programme, the Company takes significant or controlling stakes in companies operating primarily in Romania, Serbia, Bulgaria and neighbouring countries (the "Target Region"). The Company invests in investee companies where it believes New Europe Capital SRL (the "Adviser") can add value by implementing operational and/or financial restructuring over a 3 to 5 year horizon. The Company only makes an investment under the Private Equity Programme if its Adviser believes there is a clear exit strategy available, such as trade sale, break up and subsequent disposal of different divisions or assets, or flotation on a stock exchange.

 

Trading Programme

Under the Trading Programme, the Company aims to generate short and medium term returns by investing such portion of its assets as determined by the Directors from time to time in listed equities and fixed income securities, including convertible and other mezzanine instruments, issued by entities in the Target Region. The Trading Programme differs from the Private Equity Programme in the key respect that the Company will typically not take significant or controlling stakes in investee companies and will typically hold investments for shorter periods of time than investments made under the Private Equity Programme.

 

Value Creation

Under its Private Equity Programme, the Adviser is involved at board level in the investee company to seek to implement operational and financial changes to enhance returns. As part of the Company's pre-acquisition due diligence, the Adviser seeks to identify specific actions that it believes will create value in the target investee company post acquisition and, where appropriate, seek to work with third party professionals to develop, in combination with the proposed management team of the target, a value creation plan with clear and identifiable short and medium term targets. These plans are likely to address different parts of the business and are tailored to reflect the specific challenges of the relevant target company. The Adviser believes that the investment strategies under the Private Equity and Trading Programme can achieve returns which are different than the returns of the relevant market indices.

 

Investing Restrictions and Cross-Holdings

The Directors and the Adviser have sought to ensure that the portfolio of investments is sufficiently diversified to spread the risks of those investments. The Investment Strategy does not restrict the Company from investing in other closed-ended funds operating in the Target Region. In line with the Company's investment policy, the Board does not normally authorise any investment in a single investee company that is greater than 20 per cent of the Company's net asset value at the time of effecting the investment and in no circumstances will it approve an investment in a single investee company that is greater than 25 per cent of the Company's net asset value at the time of effecting the investment.

 

Change of investment objective and policy of the Company

Following the annual general meeting of the Company on 14 December 2012, the investment objective and policy of the Company were amended such that no new investments will be made. Further investments into existing portfolio companies will be permitted in certain circumstances pending their realisation and, following each realisation, all proceeds will be returned to Shareholders after paying outstanding liabilities and setting aside a sufficient amount for working capital purposes.

 

Gearing

The Company may borrow up to a maximum level of 30% of its gross assets (as defined in its articles).

 

Distribution Policy

The Company's investment objective is focused principally on the provision of capital growth. For further details of the Company's distribution policy, please refer to the Admission Document on the Company's website.

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

FOR THE YEAR ENDED 31 DECEMBER 2014

 

31-Dec-14

31-Dec-13

EUR

EUR

Investment income/(loss)

Gain/loss on investments at fair value

through profit and loss

4,747,123

(4,139,530)

Interest income

104,949

449,689

Dividend income

1,527,111

1,786,545

Other income

140,883

111,693

Total investment income/(loss)

6,520,066

(1,791,603)

Expenses

Impairment on loan receivables

-

(1,915,317)

Operating expenses

(1,405,276)

(1,724,249)

Total operating expenses

(1,405,276)

(3,639,566)

Operating profit/(loss)

5,114,790

(5,431,169)

Financial expenses

(889,739)

(994,901)

Loss before taxation

4,225,051

(6,426,070)

 

Income tax expense

 

 

 

(14,713)

 

(10,353)

Profit/(loss) for the year

4,210,338

(6,436,423)

 

Other comprehensive income

Amounts that maybe reclassified to profit or loss

Exchange differences on translating foreign operations

19,129

3,835

 

Total comprehensive income/(loss) for the year

4,229,467

(6,432,588)

 

Net income/(loss) for the year attributable to:

- Equity holders of the parent

4,241,776

(6,459,070)

- Non-controlling interest

(31,438)

22,647

4,210,338

(6,436,423)

Total comprehensive income/(loss)attributable to: 

 

- Equity holders of the parent

4,243,209

(6,458,782)

- Non-controlling interest

(13,742)

26,194

 Total comprehensive income/(loss) for the year 

4,229,467

(6,432,588)

 

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

FOR THE YEAR ENDED 31 DECEMBER 2014

 

31-Dec-14

31-Dec-13

EUR

EUR

Earnings Per Share attributable to the equity shareholders of the Company

 

 

Basic undiluted earnings per share

0.0424

(0.0646)

Fully diluted earnings per share

0.0261

(0.0646)

 

 

 

 

 

 

 

 

CONSOLIDATED STATEMENT OF FINANCIAL POSITION

AS AT 31 DECEMBER 2014

 

31-Dec-14

31-Dec-13

Assets

EUR

EUR

Non-current assets

Property, plant and equipment

10,518

10,305

Financial assets at fair value through profit or loss

44,085,288

37,983,957

Loans receivable

1,409,796

-

Total non-current assets

45,505,602

37,994,262

Current assets

Financial assets at fair value through profit or loss

342,696

369,656

Trade and other receivables

276,274

365,859

Loans receivable

-

3,215,156

Cash and cash equivalents

768,606

350,142

Total current assets

1,387,576

4,300,813

Total assets

46,893,178

42,295,075

Liabilities

Current liabilities

Trade and other payables

847,194

4,726,550

Loans and borrowings

44,190

4,306,163

Corporation tax payable

2,211

1,792

Total current liabilities

893,595

9,034,505

Non-current liabilities

Convertible loan notes

7,976,965

-

Total non-current liabilities

7,976,965

-

Total liabilities

8,870,560

9,034,505

Total net assets

38,022,618

33,260,570

 

 

 

CONSOLIDATED STATEMENT OF FINANCIAL POSITION

AS AT 31 DECEMBER 2014(Continued)

 

31-Dec-14

31-Dec-13

EUR

EUR

Capital and reserves attributable to equity holders

Share capital

1,000,000

1,000,000

Share premium reserve

121,900,310

121,900,310

Retained deficit

(85,758,495)

(90,000,271)

Equity component of convertible loan notes

629,445

-

Foreign exchange reserve

(26,245)

(27,678)

Total equity and reserves

37,745,015

32,872,361

Non-Controlling Interests

277,603

388,209

Total equity

38,022,618

33,260,570

 

31-Dec-14

31-Dec-13

EUR

EUR

Net Asset Value per share

Basic undiluted net asset value per share

0.3775

0.3287

Fully diluted net asset value per share

0.2812

0.3287

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CONSOLIDATED CASH FLOW STATEMENT FOR THE YEAR ENDED

31 DECEMBER 2014

 

31-Dec-14

31-Dec-13

EUR

EUR

Cash flows from operating activities

Net profit/(loss) before tax

4,225,051

(6,426,070)

Adjustments for:

Depreciation and amortisation

2,588

3,315

(Gain)/loss on financial assets at FVTPL

(4,747,123)

4,066,936

Impairments on loans receivable

-

1,915,318

Interest income

(104,949)

(449,689)

Interest expense

889,739

994,901

Dividend income

(1,527,111)

(1,786,545)

Net cash outflow before changes in working capital

(1,261,805)

(2,745,412)

(Increase)/decrease in trade and other receivables

68,870

(93,984)

(Decrease)/increase in trade and other payables

(3,990,128)

694,304

Sale of financial assets

-

40,498

Interest income received

387

-

Dividends received

1,526,708

1,792,446

Cash (used)/generated by operating activities

(3,655,968)

751,429

Income tax paid

(14,666)

(53,212)

Net Cash(used)/generated by operating activities

(3,670,634)

698,217

Cash flows from investing activities

Purchase of property, plant and equipment

(2,059)

(500)

Proceeds of loans granted to unconsolidated subsidiaries

594,943

40,000

Payments of loans granted to unconsolidated subsidiaries

-

(756,000)

Net cash flow generated/(used) in investing activities

592,884

(716,500)

Cash flows from financing activities

Payments of loans granted by related parties

(4,256,045)

(993,402)

Dividends paid to non-controlling interests

(96,864)

-

Proceeds from the issuance of convertible loan notes

8,449,999

-

Interest paid on loans

(622,255)

-

Net cash generated/(used) in financing activities

3,474,835

(993,402)

Increase/(decrease) in cash and cash equivalents

397,085

(1,011,685)

Cash and cash equivalents at beginning of the year

350,142

1,318,380

Foreign exchange gain/(loss)

21,379

43,447

 

Cash and cash equivalents at end of the year

 

 

768,606

 

350,142

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR EBLFFEQFFBBZ
Date   Source Headline
19th Dec 20237:00 amRNSCancellation - Reconstruction Capital II Limited
18th Dec 20237:00 amRNSDelisting and cancellation of trading
15th Dec 20233:32 pmRNSShare Dealing
12th Dec 20239:57 amRNSShare Dealing
8th Dec 202310:40 amRNSShare Dealing
29th Nov 202312:10 pmRNSResult of AGM
21st Nov 20239:34 amRNSShare Dealing
13th Nov 20234:21 pmRNSQuarterly Update
1st Nov 20237:00 amRNSProposed Cancellation & AGM Notice
31st Oct 202310:46 amRNSNet Asset Value and Policolor Material Error
28th Sep 202312:56 pmRNSLoan to Telecredit IFN S.A.
30th Aug 20239:46 amRNSInterim Unaudited Financial Statements
8th Aug 20232:45 pmRNSQuarterly Update
20th Jul 20239:21 amRNSNet Asset Value
23rd Jun 20235:00 pmRNSLoans to Telecredit IFN S.A.
9th Jun 202312:03 pmRNSAnnual Report and Audited Financial Statements
16th May 202311:25 amRNSNet Asset Value and Quarterly Report
11th Apr 20233:44 pmRNSNet Asset Value and Quarterly Report
30th Mar 20238:44 amRNSNew Valuations of Private Equity Positions
9th Jan 202312:38 pmRNSDirector Dealing
15th Dec 20228:59 amRNSLoan Facility
14th Nov 20224:59 pmRNSExtension of maturity date of loans to Telecredit
9th Nov 202212:56 pmRNSQuarterly Update
8th Nov 202211:34 amRNSJudgment in litigation against Romar
20th Oct 202211:31 amRNSNet Asset Value and Quarterly Report
5th Sep 202211:27 amRNSTransaction in Own Shares
17th Aug 20223:28 pmRNSInterim Unaudited Financial Statements
12th Aug 20223:55 pmRNSQuarterly Update
26th Jul 20222:23 pmRNSNet Asset Value
15th Jun 20227:00 amRNSAnnual Report and Audited Financial Statements
17th May 20222:56 pmRNSQuarterly Report
11th May 20222:43 pmRNSTransaction in Own Shares
10th May 20227:46 amRNSExtension of the maturity date of loans
4th May 20222:49 pmRNSNet Asset Value
14th Apr 202212:00 pmRNSNet Asset Value and Quarterly Report
6th Apr 202210:04 amRNSNew Valuations of Private Equity Positions
22nd Dec 20211:54 pmRNSLoans to Telecredit IFN S.A.
16th Nov 202110:06 amRNSQuarterly Report
16th Nov 20219:55 amRNSLoans to Telecredit IFN S.A.
20th Oct 202111:32 amRNSSeptember 2021 NAV Announcement
18th Oct 202112:14 pmRNSLoans to Telecredit IFN S.A.
9th Sep 20212:28 pmRNSDirector Appointment
17th Aug 20217:00 amRNSInterim Unaudited Financial Statements
9th Aug 20211:51 pmRNSQuarterly Report
28th Jul 20212:05 pmRNSNAV Announcement
28th Jul 20212:04 pmRNSDirector Resignation
7th Jun 202112:29 pmRNSAnnual Financial Report
11th May 20211:19 pmRNSQuarterly Report
11th May 20218:42 amRNSLoans to Telecredit IFN S.A.
4th May 202111:01 amRNSNet Asset Value

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.